About this Research Topic
Cancer care is undergoing a transformative evolution with the integration of innovative diagnostic techniques and precision treatment approaches. The extracellular matrix (ECM) is a complex network of proteins and other molecules that provide structural and biochemical support to surrounding cells in tissues. It plays a critical role in maintaining tissue architecture and function. The ECM is composed of a variety of components, including i) Collagens, which provide structural integrity and tensile strength, ii) Elastin, which provides elasticity and resilience, iii) Glycoproteins, such as fibronectin and laminin, which help in cell adhesion and communication, iv) Proteoglycans, composed of a protein core and glycosaminoglycan chains, regulating the ECM's hydration and resistance to compression, v) Hyaluronic Acid, a glycosaminoglycan that provides lubrication and hydration. The ECM is not just a passive scaffold; it actively influences cell behavior. In cancer, the ECM undergoes significant alterations that contribute to tumor progression, metastasis, and treatment resistance. Key roles of the ECM in cancer include tumor microenvironment modulation, angiogenesis, immune evasion, and response to therapy.
Precision medicine is reshaping cancer therapy by customizing treatment plans based on the unique genetic makeup of each patient's cancer. This personalized approach not only enhances the efficacy of treatments but also minimizes adverse effects, improving the overall quality of life for patients. Techniques such as genomic sequencing, targeted therapies, and immunotherapy are at the forefront of this shift, offering new hope for patients with previously untreatable or refractory cancers.
Nanotechnology offers a range of applications in extracellular matrix (ECM) detection, providing advanced tools and techniques for improved sensitivity, specificity, and multifunctionality. These include Nanoparticle-Based Imaging, such as Quantum Dots (QDs), semiconductor nanoparticles emit light of specific wavelengths when excited and can be used to label ECM components for fluorescence imaging with high resolution and brightness. Other tools include Gold Nanoparticles (AuNPs), which are useful for enhancing contrast in imaging techniques such as optical coherence tomography (OCT) and photoacoustic imaging, and Nanosensors, such as Biosensors, incorporating nanomaterials like carbon nanotubes (CNTs) or graphene to detect specific ECM molecules (e.g., collagen, fibronectin) through changes in electrical or optical properties. Finally, Plasmonic Nanosensors, utilize surface plasmon resonance (SPR) to detect molecular interactions at the nanoscale, providing real-time monitoring of ECM dynamics, Molecular Probes such as Nanoprobes, functionalized with antibodies or ligands to target specific ECM proteins, enabling precise localization and quantification, and fluorescent Nanoparticles such as silica nanoparticles doped with fluorescent dyes, used to stain ECM components for detailed imaging.
Early detection is crucial for successful cancer treatment, and recent innovations in diagnostic tools, such as liquid biopsies, advanced imaging technologies, nanobiotechnology, and molecular diagnostics, are enabling the identification of cancers at earlier stages than ever before. These tools provide detailed insights into the genetic and molecular landscape of tumors, allowing for more accurate diagnoses and better-informed treatment decisions.
Simultaneously, precision medicine is reshaping cancer therapy by customizing treatment plans based on the unique genetic makeup of each patient's cancer. This personalized approach not only enhances the efficacy of treatments but also minimizes adverse effects, improving the overall quality of life for patients. Techniques such as genomic sequencing, targeted therapies, nanobiotechnology applications, and immunotherapy are at the forefront of this shift, offering new hope for patients with previously untreatable cancers.
The aim of this Research Topic is to highlight promising, recent, and novel research trends in ECM detection and inhibition platforms. Areas to be covered in this Research Topic include, but are not limited to:
• Novel Diagnostic methods(Applications of nanomaterials in Molecular Imaging/ detection)
• Inhibiting ECM Remodeling Enzyme
• Blocking ECM-Cell Interactions
• Modulating ECM Composition
• Enhancing Immune Response
Precision medicine is reshaping cancer therapy by customizing treatment plans based on the unique genetic makeup of each patient's cancer. This personalized approach not only enhances the efficacy of treatments but also minimizes adverse effects, improving the overall quality of life for patients. Techniques such as genomic sequencing, targeted therapies, and immunotherapy are at the forefront of this shift, offering new hope for patients with previously untreatable or refractory cancers.
Nanotechnology offers a range of applications in extracellular matrix (ECM) detection, providing advanced tools and techniques for improved sensitivity, specificity, and multifunctionality. These include Nanoparticle-Based Imaging, such as Quantum Dots (QDs), semiconductor nanoparticles emit light of specific wavelengths when excited and can be used to label ECM components for fluorescence imaging with high resolution and brightness. Other tools include Gold Nanoparticles (AuNPs), which are useful for enhancing contrast in imaging techniques such as optical coherence tomography (OCT) and photoacoustic imaging, and Nanosensors, such as Biosensors, incorporating nanomaterials like carbon nanotubes (CNTs) or graphene to detect specific ECM molecules (e.g., collagen, fibronectin) through changes in electrical or optical properties. Finally, Plasmonic Nanosensors, utilize surface plasmon resonance (SPR) to detect molecular interactions at the nanoscale, providing real-time monitoring of ECM dynamics, Molecular Probes such as Nanoprobes, functionalized with antibodies or ligands to target specific ECM proteins, enabling precise localization and quantification, and fluorescent Nanoparticles such as silica nanoparticles doped with fluorescent dyes, used to stain ECM components for detailed imaging.
Early detection is crucial for successful cancer treatment, and recent innovations in diagnostic tools, such as liquid biopsies, advanced imaging technologies, nanobiotechnology, and molecular diagnostics, are enabling the identification of cancers at earlier stages than ever before. These tools provide detailed insights into the genetic and molecular landscape of tumors, allowing for more accurate diagnoses and better-informed treatment decisions.
Simultaneously, precision medicine is reshaping cancer therapy by customizing treatment plans based on the unique genetic makeup of each patient's cancer. This personalized approach not only enhances the efficacy of treatments but also minimizes adverse effects, improving the overall quality of life for patients. Techniques such as genomic sequencing, targeted therapies, nanobiotechnology applications, and immunotherapy are at the forefront of this shift, offering new hope for patients with previously untreatable cancers.
The aim of this Research Topic is to highlight promising, recent, and novel research trends in ECM detection and inhibition platforms. Areas to be covered in this Research Topic include, but are not limited to:
• Novel Diagnostic methods(Applications of nanomaterials in Molecular Imaging/ detection)
• Inhibiting ECM Remodeling Enzyme
• Blocking ECM-Cell Interactions
• Modulating ECM Composition
• Enhancing Immune Response
Keywords: nanobiotechnology, ECM, molecular imaging, biomarker detection, proteomics, ECM treatment
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
